Add to ORKGAbout 40 % of patients with non-small-cell lung cancer (NSCLC) present with stage IV disease, while resectable early stages I–II and marginally resectable locally advanced stage III each represent one-third of the patients, respectively. Th
More than 170 000 new cases and 150 000 deaths have occurred in 2003 in US owing to lung cancer, whi...
Haiyong Wang,1,* Lei Yan,1,* Cheng Li,2 Zhehai Wang1 1Department of Internal Medicine-Oncology, Shan...
Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited nu...
Non-small cell lung cancers (NSCLC) are different today, due to the increased use of screening progr...
Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selecte...
AbstractSurgical resection remains the standard of care for functionally operable early-stage non-sm...
Abstract: Purpose of review Locally advanced non-small cell lung cancer (NSCLC) represents a therape...
Surgery plays a major role in the management of patients with lung cancer. Surgery is not only the m...
Perhaps no topic other than stage IIIA-N2 non-small-cell lung cancer management is as controversial ...
Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selecte...
Locally advanced, stage IIIA-N2 Non-small cell lung cancer (NSCLC) represents a heterogeneous patien...
BackgroundFor patients with advanced stage non-small cell lung cancer (NSCLC), chemotherapy and chem...
【Abstract 】 The role of surgery in stage A-N2 non-small cell lung cancer (NSCLC) remains controversi...
Background: Surgery has been considered the most effective and standard treatment modality in non-sm...
IntroductionIn most patients with NSCLC, the disease is diagnosed in an advanced stage, the prognosi...
More than 170 000 new cases and 150 000 deaths have occurred in 2003 in US owing to lung cancer, whi...
Haiyong Wang,1,* Lei Yan,1,* Cheng Li,2 Zhehai Wang1 1Department of Internal Medicine-Oncology, Shan...
Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited nu...
Non-small cell lung cancers (NSCLC) are different today, due to the increased use of screening progr...
Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selecte...
AbstractSurgical resection remains the standard of care for functionally operable early-stage non-sm...
Abstract: Purpose of review Locally advanced non-small cell lung cancer (NSCLC) represents a therape...
Surgery plays a major role in the management of patients with lung cancer. Surgery is not only the m...
Perhaps no topic other than stage IIIA-N2 non-small-cell lung cancer management is as controversial ...
Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selecte...
Locally advanced, stage IIIA-N2 Non-small cell lung cancer (NSCLC) represents a heterogeneous patien...
BackgroundFor patients with advanced stage non-small cell lung cancer (NSCLC), chemotherapy and chem...
【Abstract 】 The role of surgery in stage A-N2 non-small cell lung cancer (NSCLC) remains controversi...
Background: Surgery has been considered the most effective and standard treatment modality in non-sm...
IntroductionIn most patients with NSCLC, the disease is diagnosed in an advanced stage, the prognosi...
More than 170 000 new cases and 150 000 deaths have occurred in 2003 in US owing to lung cancer, whi...
Haiyong Wang,1,* Lei Yan,1,* Cheng Li,2 Zhehai Wang1 1Department of Internal Medicine-Oncology, Shan...
Oligometastatic non-small cell lung cancer (NSCLC) is metastatic disease that refers to a limited nu...